Reuters Health Report

Click to View in Browser 03/28/2014 FDA staff review raises questions about MannKind diabetes device WASHINGTON (Reuters) - An initial review of MannKind Corp's experimental inhaled insulin device by U.S. Food and Drug Administration staff raised questions about its safety and effectiveness but was less damning than some investors had expected, sending the company's shares up as much as 10.6 percent. GSK lifts emerging market bet with full control of Indonesia arm LONDON (Reuters) - GlaxoSmithKline is betting more on Indonesia by taking full control of its consumer healthcare unit in the country, underscoring a drive by the drugmaker to build up its presence in fast-growing emerging markets. Idera says drug safe, well tolerated in skin disease study (Reuters) - Idera Pharmaceuticals Inc said its lead experimental drug for the most common form of psoriasis was found to be safe and well tolerated by patients after 12 weeks of treatment in a mid-stage trial. GN Store Nord's iPhone hearing aid boosts U.S. customer base COPENHAGEN (Reuters) - Danish hearing aids group GN Store Nord has seen a jump in its U.S. costumer base following the launch of a new product developed jointly with Apple for the iPhone, the company told analysts at an industry conference in Orlando. Obamacare enrollment tops six million as deadline looms: White House WASHINGTON (Reuters) - More than 6 million people have now signed up for private insurance plans under President Barack Obama's signature healthcare law known as Obamacare, reflecting a surge in enrollments days before the March 31 deadline, the White House said on Thursday. GSK recalls weight-loss drug Alli in U.S. on tampering concerns LONDON (Reuters) - GlaxoSmithKline is recalling all supplies of its non-prescription weight-loss drug Alli in the United States and Puerto Rico after customers reported finding other pills and tablets in some bottles. U.S. advisers back DNA-based colon cancer test (Reuters) - A colon cancer screening method that analyzes DNA from stool samples won the unanimous backing of a U.S. advisory panel on Thursday, paving the way for potential regulatory approval of the non-invasive test. Smoking bans cut premature births and child asthma attacks LONDON (Reuters) - Banning smoking in public places has helped to cut premature births by 10 percent, according to new research from the United States and Europe. Optimism linked to healthier eating among women NEW YORK (Reuters Health) - Women with a sunny disposition may also have an easier time adopting healthy habits, according to a new study. Self injury information available online, but rarely accurate NEW YORK (Reuters Health) - Keywords related to self-injury were searched more than 42 million times in the past year, according to a new study, but what those searches turned up was mostly myths and misinformation. Related Video Crews comb through debris, following Washington mudslide Beijing pollution reaches dangerous levels The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend